Bioorganic and Medicinal Chemistry Letters p. 803 - 806 (1996)
Update date:2022-09-26
Topics:
Chapman, Kevin T.
Durette, Philippe L.
Caldwell, Charles G.
Sperow, Kelly M.
Niedzwiecki, Lisa M.
Harrison, Richard K.
Saphos, Cheryl
Christen, Amy J.
Olszewski, Julie M.
Moore, Vernon L.
MacCoss, Malcolm
Hagmann, William K.
Further development of N-carboxyalkyl dipeptide inhibitors of stromelysin-1 (MMP-3) led to the discovery of C-carboxyalkyl dipeptide analogs with improved oral bioavailability. An in vivo assay of human MMP-3 mediated degradation of a macromolecular substrate in an extravascular space is described and inhibition studies are reported.
View MoreGuangxi Shanyun Biochemical Science and Technology Co., Ltd
Contact:+86-0772--6828887
Address:#2 Industrial Park of Luzhai County, Liuzhou, Guangxi, China
Zhengzhou Xinlian Chemical Tech Co. ,Ltd
Contact:0371-65771781 021-52042910
Address:H Part, Building I, No. 700 Gonglu Road, Pudong New Area, Shanghai
Contact:+8613400661290
Address:No 908,Kangwan Rd, Liuyang Economic
Wuxi Highness Chemical Co.,Ltd
website:https://www.phtpharmatech.com/
Contact:86-510-81771080
Address:No58 East Xinguan Rd, Guanlin Town, Yixing City, Jiangsu China
Weifang Arylchem Chemical Co., LTD
Contact:86-536-5217866
Address:Development Zone, Shouguang, Shandong Province
Doi:10.1016/0008-6215(67)85008-0
(1967)Doi:10.1021/om990385y
(2000)Doi:10.1002/ejoc.201402180
(2014)Doi:10.1039/C19660000355
(1966)Doi:10.1016/0040-4039(95)00387-R
(1995)Doi:10.1021/jo00099a037
(1994)
